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“,rrch,, Tlw ,“r,,wbndr 
prfused by the Langendorff lechnique. Phasphwus.SI 
nuclear magnenc rnommce ~prctmscupy was “red LO mon- 
ilor myocnrdiil energy *o,ab”bm an* in,rwlll”lar pN 
durinn control carfwion and 30 min of toLlI ischenda 
137W, followed by 30 min of rep&km. 
Pnlreallnen, with anipnil niterfd neither left ven*ri- 
cular &v&pod presrum under uormede cOndi,ions MIT 
,k ra,e aad exte”, of depletion of adcnosins tiphmpba,e 
(ATPI and creatine phmphate during iwhemia. Intracellu- 
br acidi!k&m. however, was atknuakd. 
On reprWion, hearts from anipamil+we,realrd ani- 
Severe myocardial ischemia results in a numbrr of events. 
including depletion of high energy phosphate stores (1.2). 
intracellular acidification (3.4). loss of ionic homeoaws and 
mitwhondtial -nd membrane damage (5). ubimately leading 
lo cell dealh. To date. the exact sequence of events and the 
relative importance of several contnbuting mechanisms are 
still unclear. The only way to stop this pracess. however. IS 
by timely reestablishment of coronary tlow 16). although 
after a critical period of ischemia this may paradoxically 
extend or accelerate ischemic cell damage (5.7.10. Reperfu- 
slon before Ibis critical period will cause edher uncompli- 
cated rccovcry or delayed restoration of melabolkm and 
funcrmn (“sunned myocardium”) (91. 
Because ixhemia-reperfusion damage in myacardial cells 
is asrucracd with the accumulation of calcium (Ca’ ‘) ions in 
the cyloplasm and milochondrial matrix (6.10.1 I). calcium 
antagonists have been used 13 provct the myocardium 
durmg whemia (2.12.13) and rubsequenl reperfusion 
(14.15). Several mcchanismc for their effectiveness have 
been propowd (16). mcluding afterload reduction by periph- 
eral artenal vasodilatian. uegli?c rnurmpic and chronolro- 
pxc effecrr reducing myocardisl oxygen consumption and 
coronary vasodilation and enhancement of collateral flow 
improving blood supply to the jeopardized tissue (17). The 
combination of these effects would help to maintain the 
balance of energy expenditure and supply under circum- 
stance, of Impaired oxygen and substrate availability. More 
recently. additional direct cRecrs of calcium antagonists 
have been postalnted on myocardial metabolism (181. the 
myocardial cell membrane (19) or cellular viability 03.211 
during ischcmia and repcrfusion. 
The aia of this study was to determine whether the 
prophylactic treatment of rats with snipamil. a new calcium 
antaeonw. protects the iso!ated heart during iachcmia and 
subsequent repcrfurion with regard to high energy phns- 
phate metabolism. intncellular pH and cardiac function. 
Anipamil is a highly lipophilic verapamil-type calcium anta~ 
onist intended for long-lasting antihypertensive and cardio- 
protcclivc action (22). 
The potential of phosphorw3l nuclear magnetic reso- 
nance C”P-NhlR) spectrwopy to evaluate the protective 
&ccl of a calcium antagonist was first demonstrated by 
Nunnzlly and Bottomley (23). We have used this technique 
to nondestructively follow the time course in phosphorus- 
containing mctaboliles and intracellular pH (2.4.24) with a 
sirnultanrou~ determination of Icfl ventricular function. 
Methods 
Animal preparation. Male Wistar rats. weighing 303 to 
350g. recei;edtwice dally intraperitoneal injections contain- 
ing either 5 mg/kg body weight anipamil (Knoll AGI dis- 
solved in 5% glucose solution or the solvent without the 
drug. On the 5th day of this regimen. 2 h after the last 
injection. the r& were anesthetized with ether and hepari- 
nixed: the heart was then rapidly excised. Perfusion was 
started hy the Langendorif technique at a constant pressure 
of 75 mm Hg as previously described (2). The heart was 
stimularcd throughout the experiment a 300 beatrlmin by 
two sodium chloride wick electrodes sutured to the right 
ventricle. Left ventricular pressure was measured by way of 
B perfusare-filled open caihetcr inserted through the apex 
125.261. The difference between oeak svstolic and end- 
bi&olic pressure was considered io he tlic left ventricular 
developed pressure. The hearl was placed in B 20 mm NMR 
tube with a capillary containing methylene diphosphonate 
for spectral refereace. The glass tube with the submerged 
heart was then lowered into the magnet. The effluent was 
collected in 5 min fractions for detcrminalion of coronary 
flow. Myocardial temperature was carefully maintained at 
37-c. 
NMR methods. “P-NMR spectra were obtained on a 
Bruker MS. 2M) spectrometer equipped with a 4.7 testa 
vertical bore magnet. No field frequency lack was used. Five 
minute spatra were obtained from 128 accumulated free 
induction decays after 90” pulses rcpeatcd at 2.3 s intervals. 
The data were accumulated using a Zk timetable and 5,oW 
Hz spcctml width. Exponential multiplication resulting in IO 
Hz line broadening was applisd and barclinc correction was 
performed on the spectra. Figure I shows typical examples 
of spectra vbtained during preiochemic control perfusion of a 
hean from an untreated (A) and an anipamil-pretreated rat 
Figure 1. “P.NMR yJcctr* and Sim”ltll”eO”S left ventriculsr pm- 
sure recordings hm an untreated (b,C.E) and an anigamil- 
pretreated (B,D,PI rat hean during control perfusion tA,B). between 
I5 and 20 min of irchemia tC,I)) and bstwen 25 and 30 min of 
reperfusirn OS). Numbered peakr arc: I, extracellular inorganic 
phosphate Cl’,); 2. intracellular P,: 3. creatine phasphate:4,5,7. Y. ~1. 
and pphosphatc group of adenosine Idphosphate; and 6. nicotin- 
amide admine dinucleodde. 
(B). Intro- and extracellular pH were calculated from the 
chemical shift of the respective inorganic phosphate peaks 
relative to methylene diphosphonate. Zero pans per million 
was assigned to creatine phosphate (2.4). Quanlitalion of 
metabolites was achieved by integrating the areas under 
individual peaks of interest in each rpoctrum, with the 
beta-phosphate peak of adenosine triphosphate (ATP) rep- 
resenting ATP levels. Data on high energy phosphate metab- 
cditcs are prcscnted OS changes relative to the average of 
three successive control measurementr preceding whcmna. 
Dala were processed in a blinded fashton. Level5 of intra- 
cellular in&ans phosphate (P,) are erprcsxd as a percent- 
age of the total amount of phosphate groups from creatine 
phosphate 0). ATP md intracellular P, durmg prewhemic 
control perfusion: 
P,,lCP + 3ATP + PI i,>“l,d Vr(“\,“” x I’m. 
Creatine phosphate and intracellular Pi were corrected for 
partial saturation; the saturation fxtors 1.5 and II. re-pec- 
lively. were determined using a IO s recycle time. 
Experimental pmtowl. After 30 10 35 min of control 
perfusion, all hear% were made totally whemic for 30 min 
by cross-clamping the perfusion line: th19 permd was fol- 
lowed by 30 min of repwfusion. During the control period 
the hearts were allowed IO smbitize for about 15 mm. 
Subsequently, three spectra were recorded during control 
perfusion. six during ischemia and six during repcrfusion. 
StaIistieal analysis. Results are prewnted as mean i 
standard deviation (SD) of 25 anipamil and 13 comrol 
experiments. Because consecutive mwurements were per- 
formed o,n each heart to establish the time course in phuz- 
phorus-containing metabolites and pH. differences between 
treated and untreated hearts were statistically evaluated by 
“analysis of variance with repeated measurements” (27.281. 
A test result with a p value <O.OS uw considered significant. 
Dataon inchemia and reperfusion were treated separately. In 
addition, data un creatine phosphate. ATP and intracellular 
P, during reperfusion were analyzed for the ~~:urrcnce of a 
steady state. as were pH dam during ixhemia. 
Results 
Myocardial functionandromnary Row. Typical examples 
of IeR ventricular pressure recordings obtained durmg con- 
trol perfuston, ischemia and reperfueion from an untreated 
and an anipamil-pretrca!cd hcan are shcwn in Figure I 
Table I summarizes valuer for left ventricular developed 
pressure and end-diastolic pressure dunng preirchcmic con- 
trol perfusion and at the end of repsrfoxon. During cooiiol 
perfuuon there wa\ no Ggnificant ddierence III wntractile 
performance between aoipamd-pretreated and untreated 
heart\. wherra, fun&mal rerovery after tcchemm and rc- 
pcrfuGun ww Gguilcantly better m the anipamil group. 
Moreover. commcture. as mdicated by the mcresse m 
end-diauolic prearurc. was less pronounced in treated 
heart<. Dunno ischemia. left ventricular developed pressure 
decreased rapldly to zero m both group, and the period of 
~tdl detectable contractile activity wa> equal 12.5 to 3 min). 
On repeifu\~on, coowdction usually began wrh a period of 
ventricular fibrillation or chaotic venlricular arrhythmia. 
which gradually gave way 10 %ahle cuntractk fuuncuon. As 
(hi, procc% showed large vnriatmns. only wlue~ fur lcfl 
ventncular developed prewrc BL the end of reperfusian are 
prewntrd. 
Cwonnn jiw during prew_hemtc control perf. .ion in 
trcaled heart> was not rigniticantly ditTcrent from Row m 
untrcatcd hearts (Table I). md,catmf that them w<** no 
vasodilauon due to anipamil pretreatment. Lke recovery of 
mcchanicdl function, restoration of coronary flow on rcper- 
fucion was more complete in the anipamil group and even 
exceeded Row rates during control perfusion. In untreated 
,xxtz d corwderable reduction m coronary flow was ob- 
served after irchemia. 
NMR spectwse~y: creatiae phosphate, ATP and inor- 
ganic phosphate (9). Figure I ihaws examples of “P-NMR 
>pcc:ra wrh cimutraneous left ventricular prerulre record- 
mgs dunng control perfusion (A and 8). between IS and ?O 
min of ischemia (C and D) and at the end of reperfu\ion (E 
and F). oblained from an untreated heart IA.C.E) and a hear1 
from an anipamd-pretreated rat (B.D.D. They illustrate the 
simdarity of untreated and anipamd-pretreated heart5 in 
phorphorus-conmining metabolites during control perfucion 
and nschemia. but not during reperfusmn. Figure 2 wnma- 
rizc, cremine phosphate. ATP and intracelhdar P, levels in 
hearts from untreated and anipamil-pretreated rats during 
ischemia and reperfusion. The depletion of high energy 
phosphate\ during ischemia. which WBS balanced by a simul- 
taneous accumulation of intracellular P,. was similar in both 
grOUp5. 
Fig”.. 2. &Tea of prelreatmcnt 0‘ rats with aniprmil on the time 
courx in lrwls of (Al creatine phosphate (CPI: tB) a&amine 
triphorphate (ATPI: and (Cl intrdcelluldr inorganic phosphate IPi) as 
mrarured ~4th “P-NMR in is&led perfused beans submitted 10 30 
mm of normothermic global irchemia followed by 30 min 01 repec 
fusion. CP and ATP levels are exprerred as a percent of [heir 
rwect~~e Preirchcmic YLIJUCS. Inlracellular P, is expressed as a 
prcent of the amow,: of phosphalc .qoups rrom CP. ATP and 
intracellular P, during Preischemic conlrol PerWon: p,I[CP + 
3.41 P + P,l,,,,,.h,,g x I@??& Mcarurements were obtamed from 
consec~~we 5 min ‘P-NMR spectra. Each point represents the 
mean 2 SD of25 anipamil-pretreated or 13 unlreated heanr. During 
irchemia. treated and unlreated hearts were not dilkrent. whereas 
dun”% reperklo”. recovery olCP and ATP war sign~ticantly hefter 
in treated hearts and intracellular P, levels were lower. *p < o.woI 
WRUI untreakd 
Figurel. Effect of pretreatment ofrats with anipamil on intracellular 
pH of their isolated perfused hean during 30 min of @A: ischemia 
followed by 30 min of reperfuusion. 8s assessed with “P-NMR 
rpettroscopy. During reperfurion of the untreated heart, a complex 
pattern in the intracellular P, region was observed. corresponding 
wilharange ofinlraceltularpH valuestree Fig. tE1.Tbe highestand 
lowest values are indicated by the uppr and tower dprbrd C-, 
respectively. Each paint represents the mean t SD of25 pretreated 
or 13 untreated beans. After 10 min of isehemia, pH in trealed 
hearts was significa”,ly higher than in untreated hcans. ‘p < (L.oWt 
versw untreated. 
were replenished, the difference between treated and un- 
treated hearts being significant (p 4 O.CH~OII. Recovery of 
ATP in snipamil-pretreated hearts was also better than in 
untreated hearts (p < 0.0001). but no complete restoration of 
ATP was found. Statistical analysis indicated that after IO 
min of repelfusion. no further improvement of high energy 
phosphate metabolites occurred. Pretreatment with anipamil 
also helped to restore low levels of intracellular Pi; in 
uu:reated hearts, intracellular P, levels remained elevated 
even after30 min ofreperfusion and were significantly higher 
than in treated hearts (p < O.lWll). The major changes in 
intracellular P. levels took place during the first IO min of 
rewrfusion. but no real steady state was reached. 
Ir~lracellular PH. During preischemic control petfusion 
intracellular pH was noiakected by pretreat& with 
anipamil (Fig. 31, but after 10 min of ischemia acidification of 
the cytosol was attenuated as compared with that in un- 
treated hearts (p < O.MlOl). Unlike depletion of high energy 
phosphates during ischemia. which was unat%cted by ani- 
pamil pretreatment, pH values stabilized at a higher level in 
the heart ofthe anipamil-pretreated rat than in the untreated 
heart. 
During reperfusion, intracellular DH rwidlv rccovcred to 
preischemic ;alues in treated hearts. wh&i in untreated 
hearts the “P-NMR spectra were often characterized by 
the presence of multiple intracellular P, peaks (Fig. IE) 
corresponding with different pH values within the myacar- 
dium 1?9l. De\pile Ihi* incomplere or ~nhomoycncou~ rcper- 
fusion. the man P. ocak corrswondcd with tin ok, ~‘7 00 10 
7.1”. 
These rcwlr~ dcmonsimle rha, ,he t&ted perfused hear! 
of the rat prelre;acd wh the new alaurn anragonw anip;: 
mil is protected agains bomc of rhc elf&r\ of rota, ~wherm., 
and reperfuoo”. l”lrace,lular acidow during irchcmia xv>,\ 
attenuated. On reperfu\io”. :he heart ,n ,he amparm 
pretreated animals showed a \ignifican,ly belter rscorcrr of 
biochemical and fwclional var!able* than did the un,rca~I 
hear,. 
Previourrtudies. It isgcncraily accepted that. fir optimal 
protectlo” “gain% i,chenia-rcpierfu,ion-induced dam*pe. 
calchml antagomrrs should be present before or. a, ,hc 
!atest. durina the irchemic event 130.311. The ~ro,ectw 
effect of cal&m antagonicts is commonly attributed 10 the 
energy-sparing effect during inchem\a due 10 their “e&w 
inolropic properlies (2.7.11.13.15.32-35). I” that way. more 
energy would remain available for Ihe momtenance of cellu- 
I”r ionic homeosrasir particularly with rr~peci to wdium 
INa’) and calcium (Ca-“) ions. 
On the other hand. there is evidence that mechanisms 
unrelated 10 reduction of cardiac work may play ” role in the 
wlection exened by calcium anvdgonists. titnry and W”h\ 
(361 demonstrated that hypoxic conlraclure in elrclrically 
and mechanicallv auiesccnt mvocurdium was suooressed bv 
,A,v,mril ,mwunr,>i<~~~~ ah rrrr,mwd rc.rr<,mr;o,,,i of c ,,r- 
im,,rl /h 4 r:w iwlur4 ht,“! dwbp rqxTfim!<m a\ corn- 
pmd wlh the untreated hart. It is qucctionvble whether 
Ihi\ IX a direct consequence of vasodilaiioa by an~pan~d. 
bcc.ue coronary Row under prewhemic condi,ton% was not 
dSxcn, I” trea,ed and unlreaied hear,>. I” our experrr;.~ntal 
model. ~mpa,red reperfuc~o” after iransicnt ischrmia (no 
Mlow phcnomenonl may be due 10 endothelial cell swelling 
iind wsoconslriciio” and myoardml cell weiimg and cot+ 
,rx,ure of myocytes 01.39,. Although prcvenuon of co”, 
tr,~cwre hy anipamil (Table I) may contnbute ,J a better 
reperfurion. it may not be a complete explanation because 
mfcdlpine was found to improve coronary Row dunng reper- 
fusion wrhout reducoo” of contracture (31). WC propose 
tha, either direc! cymprorective effects ,202, b or a rapid 
rccovcry of cardiac metabolism enables a better co”troOl of 
xanwwnbrane ionic t”rxenb and cytosolic ormolarity m 
borh va\cu,ar cells and “wocytes. :hereby prevenlm~ the 
formatlo” of edema and comrac~~re. This in ,“r” will en- 
hance liswe perfusion and may funher facildare aerobic 
meubolirm. 
Intracellular pH. I” our experiments. the major ditfer- 
ence during i&hernia between treated and untrea,ed hearts 
appeared 10 be Ihe in,rdcellular pH. which stabilized at B 
~~e”dica”llv higher level in weaved hearts. A lim,ia!ion of Ihe 
diltiazem and oifedipine. thereby rxclodmg a protectwe 
effect in terms of energy co”serva,m”. OLers ( 18.20) re- 
ported pratcctio” of isolated ra, heals I” the presence of 
diltiazem. nifedipine and verapamil at such ” low concentra- 
tion th”t no negative inotropic cffec, could be observed. 
They wggesled ” direct preservation of cellular viability ,?“I 
and a direct beneficial effect on the energy metabolism of the 
coronary artery occlusion in pigs we;e altenualed by anipa- 
mil. Erezinaki et al. (21). who ligated the left anleriur 
descending coronary artery of cats in vno, found carovwro- 
lection without reduced oxygen demand in Ihe presence of 
anipamil. They proposed B direc, cytoprotective ncl~o” of 
anipamil during ischemia. Curtis cl al. 138) studied the efiecb 
of &pamil in rats in viva “Ret coronary utery lig”“on and 
observed a” animrrhyrhmic effect during &hernia w,hout 
changer of hcarl rate and bload pressure during the prc- 
ischemic period 
Biihemicol and funerional effecta of anipmd. In our 
s,“dy. no negative inotropic effect was observed I” the 
isolated heart oianipamll-pretreated rats. II is m accordance 
with this finding lhat neither the late “LX the elite”, of 
I __ 
amou”, of hydrogen ions generaled during irchemfz may 
reduce the cellular uptake of Cd’* at the onset of rcperfufurion 
by ray ufthe sarcokmmal H’INa‘ and Na‘lCa“ exchange 
mecnanwns (40). Because uncontrolled influx of Ca” into 
,hc ce,,? is one of the crucral steps in ,he dcvelopmen, of 
reperfusion damage (6.10.1 I b. limitation of the production of 
hydrogen ions during irchcmi” would eventually facilitate 
recovery of the myocardium. 
Tirm arc sevuul pas.Md~ cwhurion~ for rhe R~CWP 
tic,,, 01 ir~rrrrrcllrdnr uodo.vir d&x Lrhen~io in rbc aniplir- 
rrril-mn~d hmrrr. Because Ca-‘* is known 10 siimulafe the 
convcrGon of phosphorybse b into phosphorylare a, which 
isnecerrary forthe breakdow”ofglycoge”(41).limi,stionof 
0” influx during whemia would co”tribu,e to a reduction 
of glycoge” degradation and a concomitant altenualicn of 
“w&xllul”r acidosis ,421. It has been shown for %vcnl 
calciw antagonists 112.20) rhnr a limt,atio” of Ca” influx 
during ischemia can occur even in the absence of energy- 
rparing etfects. It is conwvable that such a limitalio” of 
Ca?’ anflux is “at necessarily the result of a direct interac- 
bon bewern calcium antagonists and the slow channelr, hut 
may alw ix mediaed by a reduced relea% of carechola- 
rmncb ,431. whrch activate the slow channelr and augment 
Ca” influx. It is also possible that catccholamine storc~ 
)~erc already depleted because of the pretreatment of the 
animal,. as ha, been shown for other verapamil-type calcium 
antagonists 130.44.45l. A decreased availability of catechol- 
amincs dorio ischcmia will also reduce the cyclic adenocine 
mononhowhate- IcAMP)-mediated derradation of clvco~cn. 
Aliemaiive mechanism. il is uncut&~ u.hcther% i&x 
of Ca” early during rcpcrfusion is mediated by Lhc IIOW 
channels because these may be inactivated by acidosis and 
dephosphorylation (46). In most studies (31-33) the presence 
of calcium antagonists only during reperfusian failed to 
reduce rcpcrfusion damage. However, Weishaar and Bing 
(35) suggested a limitalion of the massive Ca’+ influx during 
reperfuion by diltiazem. More likely routes lor Ca” entry 
are the Na’lCa” exchange mechamsm 1401, as mentioned 
before, and an mc;eased membrane permeability for Cal* 
(6.20.47). 
TIwre/orc. r/w prnr~erion cxmrd hy mdpomil nmy oh 
be relmd m c$wrs on rks w/i awmhmrre. In particular. the 
phenylalkylamines (hke verapamll and anipamd) are sup- 
posed to exe” their ellects by initially dissolving into the 
phospholipid bilayer and subsequently migrating toward the 
slow channels (48). Anipamil would be a perfect candidate 
for such a mode of action because of its highly lipophilic 
properties. In addition. its presence in the phospholipid 
bilayer could make the sarcolemma less sensitive to Ca”- 
induced conformational changes during ischemia and reper- 
fusion (491. By maintaming sarcolemmill integrity (19) during 
ischcmia and repcrfwion. excessive entry of Ca”* and 
irreversible cell damage would t!len be prevented. Add,- 
tional experiments will bc needed to elucidate the exact 
mechanism of myocardial protection by anipamil. 
Conclusions. Pretrca!mwr of rats with anipamil pro- 
tected thee isolated heart against ischemia-reperfusion-in- 
ducsd damage. In contrast to mosl in vitro-studies with 
calcium antagonists. in which pmlecrion can bc attributed to 
a negalivc inotmpic etTeect hat in the in viva situation might 
be overcome by compensatory mechanisms. in our experi- 
ments pretreatment with anipamil did not impair contractile 
pcrfommnce of the heart. Because anipamil appeared to be 
an e&live drug to prevent the aggra&ion o~‘acceleration 
of ischemic dar.mge by repelfusion. it may be a promising 
tool forcbnical practice in which rcpcrfuaion is of increasing 
importance. 
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